Abstract
Long-acting, reversible contraceptives are about 20 times more effective in terms of contraceptive efficacy than oral hormonal contraceptives, patch or vaginal ring are. Long-acting, reversible contraceptives are not associated with serious adverse events but induce changes in menstrual bleeding pattern in about 75% of the users. The progestogen intrauterine device is effective in the treatment of menorhagia and dysmenorrhoea. Increased use of long-acting reversible contraceptives is expected to reduce unplanned pregnancies and legal abortions in all ages. Concomitant use of barrier methods is important to prevent sexually transmitted diseases.
Bidragets oversatte titel | Contraception for young women with focus on long-acting, reversible contraceptives |
---|---|
Originalsprog | Dansk |
Artikelnummer | V04170314 |
Tidsskrift | Ugeskrift for Læger |
Vol/bind | 180 |
Udgave nummer | 4 |
Sider (fra-til) | 342-345 |
ISSN | 0041-5782 |
Status | Udgivet - 1. jan. 2018 |